Unique ID issued by UMIN | UMIN000059006 |
---|---|
Receipt number | R000067486 |
Scientific Title | Randomized Controlled Trial on the Hypotensive Effect of Water-Soluble Silicon |
Date of disclosure of the study information | 2025/09/05 |
Last modified on | 2025/09/05 15:01:38 |
Randomized Controlled Trial on the Hypotensive Effect of Water-Soluble Silicon
Randomized Controlled Trial on the Hypotensive Effect of Water-Soluble Silicon
Randomized Controlled Trial on the Hypotensive Effect of Water-Soluble Silicon
Randomized Controlled Trial on the Hypotensive Effect of Water-Soluble Silicon
Japan |
Healthy adults
Adult |
Others
NO
Social interest in functional foods aimed at preventing and improving lifestyle-related diseases is growing. Particularly, the efficacy of food components (water-soluble silicon) believed to have blood pressure-lowering effects is drawing attention as a non-pharmacological intervention for blood pressure control.
This study aims to verify the effects of continuous 12-week intake of water-soluble silicon on blood pressure in adults with prehypertension or stage I hypertension through a placebo-controlled, randomized, double-blind, crossover trial.
Safety,Efficacy
Blood pressure measurement, questionnaire, blood test (biochemical test)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Intervention period: 12 weeks
Intervention details: Consumption of water-soluble silicon water or placebo (distilled water with identical appearance) three times daily (3 ml per dose)
Intervention period: 12 weeks
Intervention details: Placebo (distilled water identical in appearance to water-soluble silicon water) administered three times daily (3 ml per dose)
20 | years-old | <= |
Not applicable |
Male and Female
- Age: Healthy adult men and women
- Individuals with screening blood pressure readings within the following ranges:
- SBP: 159 mmHg or lower OR
- DBP: 99 mmHg or lower
- Individuals who have received an explanation and signed the consent form of their own free will.
- SBP 160 mmHg or higher OR DBP 100 mmHg or higher
- Individuals with a BMI below 15 or a BMI of 25 or higher
- Individuals currently receiving treatment from a physician, including antihypertensive medication
- Individuals who are pregnant, breastfeeding, or may be pregnant
- Individuals with allergies to food ingredients
- Individuals with psychiatric disorders or cognitive impairment making informed consent difficult
- Other individuals deemed unsuitable by the principal investigator
30
1st name | Daiki |
Middle name | |
Last name | Jimbo |
Reiwa Medical Research Co., Ltd.
Medical Research Institute
2200023
401, 2-7-20 Hiranuma, Nishi Ward, Yokohama City, Kanagawa Prefecture
0452981570
info@rmr.co.jp
1st name | Daiki |
Middle name | |
Last name | Jimbo |
Reiwa Medical Research Co., Ltd.
Medical Research Institute
2200023
401, 2-7-20 Hiranuma, Nishi Ward, Yokohama City, Kanagawa Prefecture
0452981570
info@rmr.co.jp
Reiwa Medical Research Co., Ltd.
APA Corporation Co.,Ltd.
Profit organization
Ethics Review Committee of Japanese medical association of Healthcare Products
2-51-202 Kyoshin-cho, Minami Ward, Yokohama City, Kanagawa Prefecture
0452981570
info@yhd.jp
NO
2025 | Year | 09 | Month | 05 | Day |
Unpublished
Open public recruiting
2025 | Year | 08 | Month | 01 | Day |
2025 | Year | 07 | Month | 31 | Day |
2025 | Year | 09 | Month | 01 | Day |
2026 | Year | 10 | Month | 31 | Day |
2025 | Year | 09 | Month | 05 | Day |
2025 | Year | 09 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067486